Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Very High Power Ablation in Patients With Atrial Fibrillation Scheduled for a First Pulmonary Vein Isolation: the POWER-PLUS Study

NCT04784013 is registered in ClinicalTrials.gov with AZ Sint-Jan AV as lead sponsor.

NCT NCT04784013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04784013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Very High Power Ablation in Patients With Atrial Fibrillation Scheduled for a First Pulmonary Vein Isolation: the POWER-PLUS Study
Lead sponsor
AZ Sint-Jan AV
Phase
Phase 4
Overall status
Completed
Start date
March 24, 2021
Completion date
May 31, 2022
Enrollment
182 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation